Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Retained Earnings of $371.9 million for Q1 2026, up 0.81% year-over-year from $368.9 million in Q1 2025, and up 216.19% quarter-over-quarter from -$320.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Retained Earnings for 6 consecutive years, with $371.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 0.81% year-over-year to $371.9 million; the TTM figure through Mar 2026 stood at $371.9 million (up 0.81% YoY), while the FY2025 annual figure was -$320.0 million, down 24.96% from the prior year.
- Retained Earnings climbed to $371.9 million in Q1 2026 per PLNH's latest filing, from -$320.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $380.3 million in Q3 2024 and bottomed at -$320.0 million in Q4 2025.
- Historically, Retained Earnings has averaged $124.7 million across 5 years, with a median of $314.0 million in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 511.81% — and 2025, when it slumped 182.93%.
- Planet 13 Holdings' Retained Earnings stood at -$134.7 million in 2022, then jumped by 334.56% to $316.0 million in 2023, then sank by 181.06% to -$256.1 million in 2024, then declined by 24.96% to -$320.0 million in 2025, then soared by 216.19% to $371.9 million in 2026.
- Business Quant data shows PLNH's Retained Earnings at $371.9 million in Q1 2026, -$320.0 million in Q4 2025, and -$315.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | 372.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 372.51 Mn |
| Mar 31, 2026 | 371.85 Mn |
| Dec 31, 2025 | -320.03 Mn |
| Sep 30, 2025 | -315.41 Mn |
| Jun 30, 2025 | 369.38 Mn |
| Mar 31, 2025 | 368.88 Mn |
| Dec 31, 2024 | -256.11 Mn |
| Sep 30, 2024 | 380.34 Mn |
| Jun 30, 2024 | 380.32 Mn |
| Mar 31, 2024 | 325.92 Mn |
| Dec 31, 2023 | 315.95 Mn |
| Sep 30, 2023 | 314.63 Mn |
| Jun 30, 2023 | 314.03 Mn |
| Mar 31, 2023 | -143.18 Mn |
| Dec 31, 2022 | -134.70 Mn |
| Sep 30, 2022 | -82.51 Mn |
| Jun 30, 2022 | -76.25 Mn |
| Mar 31, 2022 | 307.04 Mn |
| Dec 31, 2021 | -75.16 Mn |